New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
09:08 EDTMPEL, MCP, SAAS, OGXI, ATML, RIG, THOR, SUNE, CTIC, HZNP, WAG, XONE, DDD, SSYS, FOXAOn The Fly: Pre-market Movers
HIGHER: 21st Century Fox (FOXA), up 5.8%, upgraded at Cowen following the company's Q4 earnings results... Walgreen (WAG), up 2.8% after upgraded at Cantor... inContact (SAAS), up 18.5% after upgraded at Oppenheimer and Benchmark Co. after reporting better than expected Q2 results... CTI BioPharma (CTIC), up 4.5% after Pacritinib granted fast track designation by FDA... Stratasys (SSYS), up 8.6% after reporting earnings and raising its FY14 EPS view. Peers higher as well, with ExOne (XONE) up 5.3% and 3D Systems (DDD) up 2.9%... OncoGenex (OGXI), up 11.3% after appointing John A. Bencich CFO. UP AFTER EARNINGS: Horizon Pharma (HZNP), up 14.6%... Goodrich Petroleum (GDP), up 11.1%... SunEdison (SUNE), up 7%... Transocean (RIG), up 2.8%... Molycorp (MCP), up 13.7%. LOWER: Nanosphere (NSPH), down 31%, downgraded at Craig-Hallum following the company's Q2 earnings results... Thoratec (THOR), down 26%, downgraded at Goldman and Credit Suisse following lower than expected second quarter revenues and lowering FY14 guidance... PhotoMedex (PHMD), down 10% after earnings, disclosing receipt of notice of default on credit facilities... Atmel (ATML), down 4.2%, downgraded at BofA Merrill Lynch following its Q2 earnings results... Melco Crown (MPEL), down 5.2% after earnings, reporting Taiwan branch office indicted for alleged banking violations.
News For FOXA;SSYS;DDD;XONE;WAG;HZNP;CTIC;SUNE;RIG;THOR;ATML;OGXI;SAAS;MCP;MPEL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 21, 2015
08:06 EDTSUNEVivint Solar downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Vivint Solar (VSLR) citing the takeover by SunEdison (SUNE). SunEdison's operating platform will be "considerably enhanced" by the Vivint acquisition, Deutsche tells investors. It raised its price target for the stock to $45 from $40. It also believes TerraForm (TERP) shares may see near-term pressure due to suggested$900M capital raise to finance the Vivint operating asset acquisition.
07:52 EDTSUNESunEdison price target raised to $39 from $32 at UBS
UBS raised its price target on SunEdison (SUNE) to $39 from $32 following its agreement to purchase Vivint Solar (VSLR). The firm cited its increase in MW capacity and sees execution of a global spin as the next major catalyst. UBS reiterated its Buy rating on SunEdison shares.
07:52 EDTSUNEHP announces renewable energy agreement with SunEdison
Subscribe for More Information
07:38 EDTSUNESunEdison downgraded to Neutral from Outperform at Baird
Subscribe for More Information
07:02 EDTHZNPHorizon Pharma increases offer for Depomed to $33.00 per share
Horizon Pharma (HZNP) announced that it has increased the value of its all-stock acquisition proposal to $33.00 per share from $29.25 per share, contingent on Depomed entering into good faith discussions regarding a transaction. The increased offer represents a 60% premium to the closing price of Depomed on July 6, the day prior to when Horizon's initial proposal was made public.
07:01 EDTHZNPHorizon Pharma increases offer for Depomed to $33.00 per share
05:32 EDTSUNESunEdison acquires Mark Group
SunEdison announced that it has acquired Mark Group, based in Leicester, United Kingdom, a SunEdison solar sales and installation partner. This acquisition establishes a direct sales channel for SunEdison in residential and commercial sales within the UK, providing customers with robust energy efficient products and services, and strengthens the company's global position as a renewable energy leader.
July 20, 2015
16:22 EDTSUNEOn The Fly: Top stock stories for Monday
Subscribe for More Information
12:08 EDTSUNEOn The Fly: Top stock stories at midday
Stocks on Wall Street were slightly higher at midday in the first trading day of a week that will be light on domestic economic data but heavy on earnings reports. Investors will be receiving profit reports from about 25% of the companies on the S&P 500 this week, making this the highest volume earnings week of this season. ECONOMIC EVENTS: In the U.S., no major data was released. In Europe, Greece reopened its banks three weeks after closing as the country worked out another bailout agreement. The country announced it has started the process of paying off its creditors, including the European Central Bank and the International Monetary Fund, with a bridge loan it just received. COMPANY NEWS: Lockheed Martin (LMT) agreed to buy the Sikorsky Aircraft business from United Technologies (UTX) for $9B, noting the price is "effectively reduced" to $7.1B after taking into account tax benefits resulting from the transaction. Shares of Lockheed, which also reported better than expected second quarter results and increased its fiscal year guidance, gained nearly 2% after the Sikorsky announcement and saying it will conduct a strategic review of its government IT infrastructure services business and technical services business... Shares of Morgan Stanley (MS) shares were little changed near noon after the bank reported earnings and revenue, excluding certain adjustments, that topped analysts' consensus forecasts... SunEdison (SUNE) announced a deal to acquire Vivint Solar (VSLR) for approximately $2.2B, payable in a combination of cash, shares of SunEdison common stock and SunEdison convertible notes. In connection with the proposed acquisition of Vivint Solar, SunEdison has entered into a definitive purchase agreement with a subsidiary of TerraForm Power (TERP) which, concurrently with the completion of SunEdison's acquisition of Vivint, will acquire Vivint Solar's rooftop solar portfolio, consisting of 523 MW expected to be installed by year-end 2015, for $922M in cash. Shares of Vivint rose 44% following the announcement, while SunEdison's stock gained 4% and TerraForm dropped 3%. Fellow residential solar installer SolarCity (SCTY), which is backed by Tesla's (TSLA) Elon Musk, rose 7% following the deal in the space. MAJOR MOVERS: Among the notable gainers was Exelixis (EXEL), which rallied 43% after the company reported that a study of cabozantinib in metastatic renal cell carcinoma met its primary endpoint of significant improvement in progression-free survival. The shares were indicated to rise even more in early pre-market trading, but lost some of their gains after Bristol-Myers (BMY) announced that its Opdivo study was stopped early after showing superior overall survival in a Phase 3 study of previously treated patients with advanced or metastatic renal cell carcinoma. Bristol-Myers rose a bit less than 1% to trade near $70 per share after its own announcement. Also higher was PayPal (PYPL), which gained more than 5.5% in its first day of trading after being spun out of eBay (EBAY). Meanwhile, eBay shares rose over 2%. Cal-Maine Foods (CALM) dropped 8% after posting lower than expected sales and profits in its fourth quarter and warning that while it should have an adequate supply of its primary feed ingredients, the company expects that prices will be "volatile" in the year ahead. Also lower were shares of several gold miners, including Barrick Gold (ABX) and Newmont Mining (NEM), which each fell about 11%, as gold prices declined about 2% near midday. INDEXES: Near midday, the Dow was up 31.66, or 0.18%, to 18,118.11, the Nasdaq was up 9.81, or 0.19%, to 5,219.96, and the S&P 500 was up 2.82, or 0.13%, to 2,129.46.
11:27 EDTSUNESunEdison acquisition implies higher SolarCity valuation, says Raymond James
Subscribe for More Information
10:33 EDTHZNPDepomed suitor Horizon Pharma advances after raising outlook
Subscribe for More Information
10:00 EDTFOXAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:50 EDTHZNPHorizon Pharma CEO says 'here to stick it out' regarding Depomed deal
Subscribe for More Information
09:50 EDTHZNPHorizon Pharma CEO says Depomed proposal 'shareholder friendly'
Subscribe for More Information
09:22 EDTHZNP, SUNEOn The Fly: Pre-market Movers
Subscribe for More Information
07:16 EDTHZNPHorizon Pharma up 5.2% after reporting preliminary Q2 revenue, raises FY15 view
Subscribe for More Information
07:14 EDTSUNESunEdison acquires Vivint Solar for $2.2B
Subscribe for More Information
07:05 EDTHZNPHorizon Pharma raises FY15 revenue guidance to $660M-$680M from $590M-$610M
Consensus $611.6M. Raises FY15 adjusted EBITDA guidance to $265M-$280M from $235M-$250M.
07:04 EDTHZNPHorizon Pharma sees Q2 revenue $170M-$172M, consensus $138.26M
06:25 EDTFOXA21st Century Fox downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded 21st Century Fox to Neutral and lowered its price target to $34 from $40. The firm sees uncertainty around FY16 earnings given increasing programming costs, further investments, and potential acquisitions, and has a mixed views on the company's OTT streaming position.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use